Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy
Status:
Unknown status
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This clinical trial is undertaking by Qilu Hospital of Shandong University, aims at
evaluating efficacy and safety of rhTPO in management of ITP in pregnancy.